Find Research Projects

Search results

• Active

  IMbrave050: A phase III, multicentre, randomized, open-label study of atezolizumab (anti-PD-L1 antibody) plus bevacizumab plus bevacizumab versus active surveillance as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after surgical resection or ablationR SURGICAL RESECTION OR ABLATION

  Poursoltan, P., Chapman, N. & Parshionikar, A.

  11/12/19 → 30/09/24

  Project: Other

• THE KYNURENINE PATHWAY IN NEUROINFLAMMATORY DISEASES: TRANSLATION TO PROGNOSTICS AND THERAPEUTICS

  Guillemin, G.

  30/11/19 → 29/11/24

  Project: Research

• M&A and tax framework

  Akhtar, F.

  29/11/19 → …

  Project: Research

• IPATunity170: A Phase III, Double-Blind, Placebo-Controlled, Randomized Study Of Ipatasertib In Combination With Atezolizumab And Paclitaxel As A Treatment For Patients With Locally Advanced Unresectable Or Metastatic Triple-Negative Breast Cancer

  Kefford, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.

  22/11/19 → 30/09/24

  Project: Other

• IPATunity170: A Phase III, Double-Blind, Placebo-Controlled, Randomized Study Of Ipatasertib In Combination With Atezolizumab And Paclitaxel As A Treatment For Patients With Locally Advanced Unresectable Or Metastatic Triple-Negative Breast Cancer

  Kefford, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.

  22/11/19 → 30/09/24

  Project: Other

• IPATunity170: A Phase III, Double-Blind, Placebo-Controlled, Randomized Study Of Ipatasertib In Combination With Atezolizumab And Paclitaxel As A Treatment For Patients With Locally Advanced Unresectable Or Metastatic Triple-Negative Breast Cancer

  Kefford, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.

  22/11/19 → 30/09/24

  Project: Other

• IPATunity170: A Phase III, Double-Blind, Placebo-Controlled, Randomized Study Of Ipatasertib In Combination With Atezolizumab And Paclitaxel As A Treatment For Patients With Locally Advanced Unresectable Or Metastatic Triple-Negative Breast Cancer

  Kefford, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.

  22/11/19 → 30/09/24

  Project: Other

• Identifying risk from marine debris sourced from recreational fishing and, where appropriate, determining solutions to key issues

  Lincoln-Smith, M., Blount, C., Reeds, K., McPhee, D., Williamson, J. & Zhang, D.

  4/11/19 → 30/06/24

  Project: Research

• CRE in Interactive Digital Technology to Transform Australia’s Chronic Disease Outcomes

  Oldenburg, B., Maddison, R., Kostakos, V., Boyle, D., Borland, R., Lau, A., Furler, J., Scuffham, P. A., Abraham, C., Taylor, C., Moy, C., Magrabi, F., Wadley, G., Car, J., Yan, L., Varnfield, M., Brooks, P., Absetz, P., Scibilia, R. & Mohan, S.

  1/11/19 → 31/10/24

  Project: Research

• Skills articulation through visual narratives

  Lin-Stephens, S. & Downes, J.

  31/10/19 → 31/10/24

  Project: Research

• AGCMP - SMOC+ RisC: An Australian Genomic Cancer Medicine Program for Rare and Less Common Cancers

  Thomas, D. M., Simes, J., Scott, C., Fox, S., Brown, M. P., Scott, H., Schofield, D., O'Byrne, K., Lakhani, S., Millward, M. & Young, R.

  31/10/19 → 31/12/24

  Project: Research

• Music can speak for you: making music with a deep net partner

  Dean, R. T., Hamilton, T., Walder, C., Davis, J. & Heble, A.

  31/10/19 → 31/12/23

  Project: Other

• TTVF: Transitioning Taranaki to a Volcanic Future

  Turner, S. & Cronin, S. J.

  28/10/19 → 31/03/24

  Project: Research

  File

• COSMIC: A randomized, double-blind, controled phase 3 study of cabozantinib in combination with nivolumab and ipilimumab versus nivolumab and ipilimumab in subjects with previously untreated advanced or metastatic renal cell carcinoma of intermediate to poor risk

  Gurney, H., Butala, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.

  2/10/19 → 11/07/24

  Project: Other

• COSMIC: A randomized, double-blind, controled phase 3 study of cabozantinib in combination with nivolumab and ipilimumab versus nivolumab and ipilimumab in subjects with previously untreated advanced or metastatic renal cell carcinoma of intermediate to poor risk

  Gurney, H., Butala, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.

  2/10/19 → 11/07/24

  Project: Other

• A dashboard of predictive analytics and decision support to drive care quality and person-centred outcomes in aged care

  Westbrook, J., Georgiou, A., Lord, S. R., Gray, L., Day, R., Ratcliffe, J., Baysari, M. & Braithwaite, J.

  1/10/19 → 30/09/24

  Project: Research

• A toolbox to underpin and enable tomorrow's marine biosecurity system

  Floerl, O., Zaiko, A., Hopkins, G., Cahill, P., Pochon, X., Wood, S., Davidson, I., South, P., Vennell, R., Atalah, J., Newton, M., Smeaton, M., Gemmell, N., Stanton, J., Guen, M. J. L., Welsh, M., Yao, R., Treml, E., Dafforn, K., Badyal, J. P. & Chetham, J.

  1/10/19 → 30/09/24

  Project: Other

• TTVF: Transitioning Taranaki to a Volcanic Future

  Cronin, S. J., Wilson, T., Brenna, M., Rushmer, T., Bebbington, M. S., McDonald, G., Turner, S., McCallion, A., Wang, T., Jolly, A., Wreford, A., Ukstins, I., Magill, C., Schipper, C. I. & Pardo, N.

  1/10/19 → 30/09/24

  Project: Research

• Wine, Oil and Knowledge Networks of the Graeco-Roman Cyclades

  Dodd, E.

  1/10/19 → …

  Project: Research

• GALAXI: A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease

  Leong, R., Butala, R., Chapman, N., Parshionikar, A. & Rajasekharan Nair, A.

  30/09/19 → 7/05/24

  Project: Research

• Harbour Biomed 4003.1: A Phase 1 Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of HBM4003 in Subjects with Advanced Solid Tumors

  Gurney, H., Chapman, N., Butala, R., Parshionikar, A. & Rajasekharan Nair, A.

  30/09/19 → 30/09/24

  Project: Other

• VEGA: A Phase 2a Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter, Proof-of-concept Clinical Study to Evaluate the Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

  Leong, R., Butala, R. & Chapman, N.

  24/09/19 → 11/07/24

  Project: Other

• LEAP-011: A Phase 3, Randomized, Double-blind Study to Compare the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Lenvatinib (E7080/MK-7902) Versus Pembrolizumab and Placebo as First Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma in Cisplatin-ineligible Participants Whose Tumors Express PD-L1, and in Participants Ineligible for Any Platinum-containing Chemotherapy Regardless of PD-L1 Expression: Protocol MK7902-011-00

  Zhang, A., Butala, R. & Chapman, N.

  13/09/19 → 6/06/24

  Project: Research

• Producing Knowledge in Precarity: research, universities and labour insecurity

  Dados, N.

  10/09/19 → …

  Project: Research

  File

• A Game of Thorn: What Motivates Bitcoin Miners

  Cai, C. & Bui, B.

  12/08/19 → …

  Project: Research

• KEYNOTE-641: Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  Gurney, H., Chapman, N. & Butala, R.

  8/08/19 → 5/06/24

  Project: Other

• A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer.

  Zhang, A., Chapman, N. & Butala, R.

  6/08/19 → 18/06/24

  Project: Other

• A Phase 1B, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Ipatasertib in Combination with Rucaparib in patients with Advanced Breast, Ovarian, or Prostate Cancer

  Gurney, H., Chapman, N. & Butala, R.

  5/08/19 → 26/06/24

  Project: Other

• Empathetic capacity and human-robot interaction

  Lajante, M., Tojib, D. & Ho, I.

  5/08/19 → …

  Project: Research

• An EVT Approach to Modeling Joint Extremes in Climate and Mortality

  Li, H. & Tang, Q.

  9/07/19 → 8/07/24

  Project: Research

• Goal orientations and service innovation adoption

  Tojib, D., Ho, I. & Tsarenko, Y.

  4/07/19 → …

  Project: Research

• Biobanks, Big Data and ME: establishing a global registry and biobank in Australia to drive discovery of blood biomarkers.

  Fisher, P., Nicholl, H., Gooley, P., Lidbury, B. A., Guillemin, G. & Josev, E.

  1/07/19 → 31/12/24

  Project: Research

• BPA-APAF: National Collaborative in A Rodger - BioPlatforms Australia support of Australian Proteome Analysis Facility

  Rodger, A. & Mirzaei, M.

  1/07/19 → 31/12/23

  Project: Research

• The evolution of host-parasite interactions during a biological invasion

  Shine, R. & Rollins, L.

  26/06/19 → 25/06/24

  Project: Other

• Enhancing safety and care quality for culturally and linguistically diverse cancer consumers: A consumer engagement approach.

  Harrison, R.

  4/06/19 → 31/12/23

  Project: Research

  File

• Interaction between mantle plume and oceanic lithosphere : Examples of Galápagos and Ontong Java Plateau

  Ben Mansour, W.

  31/05/19 → …

  Project: Research

• Volcanism associated with subduction zones

  Ben Mansour, W. & Aoki, Y.

  31/05/19 → …

  Project: Research

• A phase 1/2 open label, multi-center dose escalation and expansion study of combination immunotherapy CBT-501 (anti-PD-1) or nivolumab with CBT-101 (c-Met inhibitor) in locally advanced or metastatic hepatocellular carcinoma and renal cell carcinoma

  Sabanathan, D., Chapman, N., Butala, R. & Gurney, H.

  16/05/19 → 15/05/24

  Project: Other

• A phase 1/2 open label, multi-center dose escalation and expansion study of combination immunotherapy CBT-501 (anti-PD-1) or nivolumab with CBT-101 (c-Met inhibitor) in locally advanced or metastatic hepatocellular carcinoma and renal cell carcinoma

  Sabanathan, D., Chapman, N., Butala, R. & Gurney, H.

  16/05/19 → 15/05/24

  Project: Other

• DYNAMIC III: Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colon Cancer: A Multicentre Phase II/III Randomised Controlled Study

  Poursoltan, P., Chapman, N. & Cunningham, J.

  2/05/19 → 1/05/24

  Project: Other

• Building a Lifeline for the future: Expectations, innovations, outcomes

  Rickwood, D., Titov, N., Pirkis, J., Klein, B., Batterham, P. J., Epps, J. R., Goecke, R., Kolves, K., Gould, M. & Bradford, S.

  1/05/19 → 30/04/24

  Project: Other

• MQRIS: Observational Documentary Fieldwork Kit

  Murray, T., Pearlman, K., Barkat, I., Long, J., Sone, Y. & Burtt, J.

  11/04/19 → …

  Project: Other

• A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer

  Gurney, H. & Cunningham, J.

  4/04/19 → 3/04/24

  Project: Other

• OOA_SOSF: Diversity, Dynamics and Destinations of Sawsharks from South-eastern Australia

  Williamson, J.

  1/04/19 → 1/04/24

  Project: Research

• A phase III, multicenter, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive, HER2-negative, early breast cancer (New Adjuvant TriAl with Ribociclib [LEE011]: NATALEE)

  Sabanathan, D., Kefford, R. & Cunningham, J.

  21/03/19 → 20/03/24

  Project: Other

• MQRIS: Ultra High Definition Cinema Cameras

  Murray, T., Pearlman, K. & Barkat, I.

  15/03/19 → …

  Project: Other

• A Phase II Trial of single agent CABOZANTINIB in patients with locally advanced or metastatic non-clear cell renal cell carcinoma post immunotherapy or who are unsuitable for immunotherapy (ANZUP 1802)

  Gurney, H., Chapman, N., Cunningham, J. & Butala, R.

  14/03/19 → 13/03/24

  Project: Other

• Nanotechnology and Coronavirus (SARS-CoV-2)

  Rabiee, N., Ahmadi, S., Saeb, M. R., Hooshmand, S. E., Varma, R. S., Hamblin, M. R. & Rabiee, M.

  10/03/19 → …

  Project: Research

• Austral Jazz: Repertoire development through affinity cluster networks

  Robson, A.

  1/03/19 → …

  Project: Research

• A Phase 3 Randomized Open Label Study to Compare NKTR-214 Combined with Nivolumab to the Investigator's Choice of Sunitinib or Cabozantinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma

  Gurney, H., Chapman, N. & Butala, R.

  28/02/19 → 27/02/24

  Project: Other